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Structural valve failure with every beat regurgitation observed using
the Medtronic Advantage aortic valve
Lorenz Hansen, MD, Matthias Danne, MD, Bettina Hoffmann, MD, and Friedrich-C. Rieß, MD, Hamburg, Germany
Clinical Summary
A57-year-old patient received a 27-mm Medtronic Ad-vantage aortic valve prosthesis (Medtronic, Inc, Min-neapolis, Minn) for a combined aortic valve lesion.The valve was implanted with pledget-supported non-
everting mattress sutures. The axis of the valve’s central opening
was oriented toward the commissure between the left and right
coronary cusps. After implantation, leaflet function was tested with
a valve tester supplied by the manufacturer. No tissue of the native
aortic annulus or suture material could be identified through the
valve orifice. The valve was not rotated. A predischarge echocar-
diogram showed a normally functioning prosthesis with physio-
logic washing jets in the hinge area, a maximal pressure gradient
of 14 mm Hg, and an aortic valve area of 2.68 cm2.
Nine weeks postoperatively, the patient returned with dyspnea
on exertion. An echocardiogram showed an every-beat aortic re-
gurgitation grade II–III with two regurgitant jets, one of which was
considered paravalvular. On reoperation, no sign of paravalvular
leakage could be detected. The suture ring of the prosthesis was
covered with fresh endothelium. There was no clinical sign of
endocarditis, and swab testing showed no organism. The complete
valve, with particular regard to the leaflet hinges, was free of
thrombus. There was no pannus formation or interference with
suture material. In situ testing showed that the valve insufficiency
was caused by incomplete closure of the anterior leaflet opposite
the right coronary ostium. By applying gentle pressure to the
leaflet, we were able to achieve a complete closure of the valve.
Distinct leaflet interference was noticed in the valve hinge under
the commissure between the left and right coronary cusps. This
finding was reproducible. The explanted valve was returned to the
manufacturer for further investigation.
Discussion
Eichinger and associates1 reported occasional single-beat regurgi-
tation of varying intensity with the Medtronic Advantage aortic
valve after a mean follow-up of 26.2 months in 5 of 61 patients.
Fluoroscopy revealed asymmetric closure that either of the two
leaflets in the same prosthesis could affect.
Intermittent single-beat regurgitation has led to reoperations
and a valve replacement being reported to the Food and Drug
Administration in 2005. Even though a moderate grade of regur-
gitation with a recordable drop in diastolic blood pressure could be
recorded and regurgitation occurred with a frequency of up to 30
times per minute, patients with occasional single-beat regurgitation
are clinically asymptomatic. Surveillance for this type of valve
dysfunction is indicated.
In the case of the explanted valve, regurgitation was continuous
and the patient became symptomatic. Inasmuch as the dysfunction
was related to a single leaflet and apparently to a single hinge, we
classify this event as a structural failure. To our knowledge, this is
the first case of structural valve failure observed with the
Medtronic Advantage aortic valve.
Further implantation of the Advantage heart valve has been
suspended at our department.
A review of the production records by the manufacturer
showed that the implanted valve fulfilled the quality specifications,
with an opening angle slightly larger than 86°. On re-examination
of the explant, this angle exceeded 90°. A leaflet overlap was
noticed. Because the valve showed a normal function directly
postoperatively, a wearing of the pivotal areas can be suspected but
no microscopic evidence was found on the valve structure.
There are many reports in the literature about structural failures
of mechanical heart valves affecting both mitral and aortic pros-
theses. The best known is the Björk–Shiley convexo–concave
valve2 (Shiley, Inc, Irvine, Calif). Leaflet fracture with leaflet
escape was reported for different bileaflet valves of more recent
design and has led to market withdrawals. According to the fre-
quency and the mode of the reported failure, a systematic design-
or fabrication-related error is presumed.3
By contrast, sporadic reports of failing valves pertaining to
widely accepted valves with numerous implants worldwide have to
be considered.4
Different factors were identified contributing to the risk of
leaflet damage, including cavitation, asymmetric leaflet closure,
and surgical mishandling of the prosthesis.5
The mode of failure of the explanted valve remains unclear. No
intermittent regurgitation was observed before the onset of con-
tinuous insufficiency; hence a single random incident is concluded.
However, no data exist regarding the time of onset and develop-
ment of occasional single-beat regurgitation and no information is
available about any explanted specimen with this disorder. The
differing severity of intermittent regurgitation in different patients
is unexplained. Therefore, intermittent regurgitation may be re-
garded as a process, with asymmetric closure of the leaflets and
leaflet overlap causing leaflet stress and thereby structural dysfunc-
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tion. Unexpected in vivo performance of a mechanical heart valve
should be elucidated thoroughly and careful follow-up of affected
patients is warranted.
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Cardiac papillary muscle hemangioma
Andrew E. Newcomb, MBBS, FRACS,a Stefano Pelenghi, MD,a Jacek Karski, MD,b Jagdish Butany, MBBS, MS, FRCPC,c
and Tirone E. David, MD, FRCS(C),a Toronto, Ontario, Canada
Arare case of left ventricular hemangioma in combina-tion with mitral valve prolapse is reported. The neo-plasm was seen close to the tip of the posterior pap-illary muscle. The definitive diagnosis was made at
the time of postresection pathologic examination. A literature
review confirms the need for resection, if possible.
Clinical Summary
An echocardiogram on a 40-year-old man being observed for
mitral valve regurgitation revealed a 1.4-cm diameter mass on the
posterior papillary muscle. The mass had not been noted on pre-
vious examination 3 years prior. History and physical examination
were unremarkable. An angiogram confirmed 2 mitral regurgi-
tation. Results of all other investigations were within normal
limits. A clinical diagnosis of myxoma was made, and to avoid any
chance of tumor embolization, urgent surgery was scheduled.
An intraoperative transesophageal echocardiogram (TEE) con-
firmed A2 prolapse and a heterogeneous 1.7-cm diameter mass in the
left ventricle attached to chordae tendineae adjacent to the postero-
lateral papillary muscle (Figure 1). Using cardiopulmonary bypass
and hypothermic arrest, we opened the left atrium wide through the
interatrial groove. A spherical mass attached to the medial portion of
the anterior trunk of the posterior papillary muscle, approximately 1
cm below the level where the chordae tendineae attach, was identified
(Figure 2) and removed along with a 3- to 4-mm rim of papillary
muscle around the base (Figure 2, inset). The remaining muscle
looked viable and strong. The A2 prolapse was corrected with 6
polytetrafluoroethylene neochordae (Gore-Tex; registered trade mark
of W. L. Gore & Associates, Inc, Flagstaff, Ariz) between the poste-
rior papillary muscle and the free margin of the leaflet. A posterior
annuloplasty band with a Medtronic Simplici-T (Medtronic, Inc,
Minneapolis, Minn) 64 mm in length was performed.
The postprocedure TEE showed normal valvular function. The
postoperative course was uneventful and the patient was discharged
home 5 days after the operation. Follow-up review at 2 months
showed no mitral regurgitation or tumor recurrence.
Histopathologic examination revealed a 1.5-cm diameter mass
comprising vascular channels (CD31 positive cells on immunohis-
tochemical staining [antibodies from Dako Diagnostics, Missis-
sauga, Ontario, Canada]) with the histologic appearance of hem-
angioma. There were small (capillary) and large (cavernous)
vascular structures of varying sizes with variable amounts of
endothelial cells and smooth muscle cells separated by a loose,
partly myxoid matrix. The smooth muscle actin stain was also
positive in cells surrounding the vascular channels.
Discussion
Primary cardiac tumors are rare and most are benign. Hemangio-
mas account for 5% to 10% of these benign tumors.1 They may
present at any age and there is a slight male preponderance.
Hemangiomas may be found in any layer of the heart and in any
chamber; however, there is a tendency for the right heart and left
atrium to be more frequently involved.2
Microscopically, these are composed of vascular endothelial
cells and may be classified into capillary, cavernous, venous, or
racemose in nature.3 Most hemangiomas are small subendocardial
bluish nodules and range in size from 2 to 3.5 cm. They may be
sessile or polypoid and are mostly solitary.2 These tumors are
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